D. E. Shaw & Co. Inc. Sells 57,612 Shares of Phibro Animal Health Co. (NASDAQ:PAHC)

D. E. Shaw & Co. Inc. trimmed its stake in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 74.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 19,286 shares of the company's stock after selling 57,612 shares during the period. D. E. Shaw & Co. Inc.'s holdings in Phibro Animal Health were worth $405,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. Cubist Systematic Strategies LLC bought a new position in Phibro Animal Health during the fourth quarter valued at approximately $1,119,000. CastleKnight Management LP grew its position in Phibro Animal Health by 6.2% during the fourth quarter. CastleKnight Management LP now owns 389,433 shares of the company's stock valued at $8,178,000 after acquiring an additional 22,796 shares during the last quarter. Cetera Investment Advisers bought a new position in Phibro Animal Health during the fourth quarter valued at approximately $204,000. Centiva Capital LP bought a new position in Phibro Animal Health during the fourth quarter valued at approximately $266,000. Finally, Bridgeway Capital Management LLC bought a new position in Phibro Animal Health during the fourth quarter valued at approximately $1,155,000. 99.34% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research analysts have commented on the stock. Barclays increased their price target on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a research report on Monday, February 10th. Wall Street Zen upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Finally, Morgan Stanley raised their target price on shares of Phibro Animal Health from $20.00 to $21.00 and gave the stock an "equal weight" rating in a report on Thursday, May 8th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Hold" and an average target price of $20.00.

Phibro Animal Health Trading Down 0.5%

Shares of Phibro Animal Health stock traded down $0.13 on Friday, hitting $24.54. The stock had a trading volume of 165,339 shares, compared to its average volume of 200,630. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. Phibro Animal Health Co. has a one year low of $16.16 and a one year high of $26.55. The stock has a market cap of $994.50 million, a price-to-earnings ratio of 51.05, a PEG ratio of 0.45 and a beta of 0.62. The stock's 50-day simple moving average is $20.46 and its two-hundred day simple moving average is $21.90.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.63 EPS for the quarter, topping analysts' consensus estimates of $0.52 by $0.11. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. The company had revenue of $347.80 million during the quarter, compared to analyst estimates of $352.41 million. As a group, sell-side analysts predict that Phibro Animal Health Co. will post 1.95 EPS for the current year.

Phibro Animal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Wednesday, June 4th will be paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 1.96%. The ex-dividend date of this dividend is Wednesday, June 4th. Phibro Animal Health's payout ratio is 61.54%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.